This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
CD44
From Proteopedia
(Difference between revisions)
| (15 intermediate revisions not shown.) | |||
| Line 1: | Line 1: | ||
| - | < | + | <StructureSection load='2jcq' size='350' side='right' scene='' caption='Mouse CD44 hyaluronan-binding domain complex with glucuronic acid, NAG and ethylene glycerol (PDB code [[2jcq]])'> |
| + | |||
== Function == | == Function == | ||
'''CD44''' is a glycoprotein involved in cell-cell interactions. CD44 is a receptor of hyaluronic acid (HA). CD44 undergoes post-translational modification. Its sialofucosylation changes it to a form which directs migration of stem cells to bone marrow.<ref>PMID:25195884</ref> | '''CD44''' is a glycoprotein involved in cell-cell interactions. CD44 is a receptor of hyaluronic acid (HA). CD44 undergoes post-translational modification. Its sialofucosylation changes it to a form which directs migration of stem cells to bone marrow.<ref>PMID:25195884</ref> | ||
| - | *<scene name='52/523368/Cv/ | + | *<scene name='52/523368/Cv/4'>Binding site of CD44 hyaluronan-binding domain</scene> ([[2jcq]]).<ref>PMID:17293874</ref> |
== Relevance == | == Relevance == | ||
CD44 is a potential drug target for treatment of malignant neoplasms. Anti-CD44 antibody treatment lowers hyperglycemia and chronic inflammatory diseases. | CD44 is a potential drug target for treatment of malignant neoplasms. Anti-CD44 antibody treatment lowers hyperglycemia and chronic inflammatory diseases. | ||
| + | </StructureSection> | ||
| + | |||
==3D structures of CD44== | ==3D structures of CD44== | ||
Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}} | Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}} | ||
| - | [[1uuh]], [[4pz4]] – hCD44 hyaluronan-binding domain – human<br /> | + | [[1uuh]], [[4pz4]] – hCD44 hyaluronan-binding domain 18-171 – human<br /> |
[[1poz]], [[2i83]] - hCD44 hyaluronan-binding domain – NMR<br /> | [[1poz]], [[2i83]] - hCD44 hyaluronan-binding domain – NMR<br /> | ||
| - | [[2jcp]] - mCD44 hyaluronan-binding domain – mouse<br /> | + | [[4pz3]] - hCD44 hyaluronan-binding domain + tetrapeptide<br /`> |
| + | [[2jcp]] - mCD44 hyaluronan-binding domain 23-172 – mouse<br /> | ||
[[2jcq]], [[2jcr]] - mCD44 hyaluronan-binding domain + 8-mer HA<br /> | [[2jcq]], [[2jcr]] - mCD44 hyaluronan-binding domain + 8-mer HA<br /> | ||
| - | [[4mrd]], [[4mre]], [[4mrf]], [[4mrg]], [[4mrh]], [[4np2]], [[4np3]] - mCD44 hyaluronan-binding domain + inhibitor<br /> | + | [[4mrd]], [[4mre]], [[4mrf]], [[4mrg]], [[4mrh]], [[4np2]], , [[4np3]], [[5bzc]], [[5bzk]], [[5sbk]], [[5sbl]], [[5sbm]], [[5sbn]], [[5sbo]], [[5sbp]], [[5sbq]], [[5sbr]], [[5sbs]], [[5sbt]], [[5sbu]], [[5sbv]], [[5sbw]], [[5sbx]], [[5sby]], [[5sbz]], [[5sc0]], [[5sc1]], [[5sc2]], [[5sc3]], [[5sc4]], [[5sc5]], [[5sc6]], [[5sc7]] - mCD44 hyaluronan-binding domain + inhibitor<br /> |
| + | [[5bze]], [[5bzf]], [[5bzg]], [[5bzh]], [[5bzi]], [[5bzj]], [[5bzl]], [[5bzm]], [[5bzn]], [[5bzo]], [[5bzp]], [[5bzq]], [[5bzr]], [[5bzs]], [[5bzt]] - mCD44 hyaluronan-binding domain (mutant) + inhibitor<br /> | ||
[[4np3]] - mCD44 hyaluronan-binding domain + tetrapeptide<br /> | [[4np3]] - mCD44 hyaluronan-binding domain + tetrapeptide<br /> | ||
| + | |||
== References == | == References == | ||
<references/> | <references/> | ||
[[Category:Topic Page]] | [[Category:Topic Page]] | ||
Current revision
| |||||||||||
3D structures of CD44
Updated on 20-January-2025
1uuh, 4pz4 – hCD44 hyaluronan-binding domain 18-171 – human
1poz, 2i83 - hCD44 hyaluronan-binding domain – NMR
4pz3 - hCD44 hyaluronan-binding domain + tetrapeptide
2jcp - mCD44 hyaluronan-binding domain 23-172 – mouse
2jcq, 2jcr - mCD44 hyaluronan-binding domain + 8-mer HA
4mrd, 4mre, 4mrf, 4mrg, 4mrh, 4np2, , 4np3, 5bzc, 5bzk, 5sbk, 5sbl, 5sbm, 5sbn, 5sbo, 5sbp, 5sbq, 5sbr, 5sbs, 5sbt, 5sbu, 5sbv, 5sbw, 5sbx, 5sby, 5sbz, 5sc0, 5sc1, 5sc2, 5sc3, 5sc4, 5sc5, 5sc6, 5sc7 - mCD44 hyaluronan-binding domain + inhibitor
5bze, 5bzf, 5bzg, 5bzh, 5bzi, 5bzj, 5bzl, 5bzm, 5bzn, 5bzo, 5bzp, 5bzq, 5bzr, 5bzs, 5bzt - mCD44 hyaluronan-binding domain (mutant) + inhibitor
4np3 - mCD44 hyaluronan-binding domain + tetrapeptide
References
- ↑ Liu LK, Finzel B. High-resolution crystal structures of alternate forms of the human CD44 hyaluronan-binding domain reveal a site for protein interaction. Acta Crystallogr F Struct Biol Commun. 2014 Sep 1;70(Pt 9):1155-61. doi:, 10.1107/S2053230X14015532. Epub 2014 Aug 29. PMID:25195884 doi:http://dx.doi.org/10.1107/S2053230X14015532
- ↑ Banerji S, Wright AJ, Noble M, Mahoney DJ, Campbell ID, Day AJ, Jackson DG. Structures of the Cd44-hyaluronan complex provide insight into a fundamental carbohydrate-protein interaction. Nat Struct Mol Biol. 2007 Mar;14(3):234-9. Epub 2007 Feb 11. PMID:17293874 doi:10.1038/nsmb1201
